These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16945386)

  • 61. Anaesthesia in patients suffering from organophosphorus intoxication--interactions between general anaesthetics and acetylcholine in cortical networks in vitro.
    Grasshoff C; Thiermann H; Antkowiak B
    Toxicology; 2007 Apr; 233(1-3):214-22. PubMed ID: 17030394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropine.
    Shih TM; Rowland TC; McDonough JH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):154-61. PubMed ID: 17015638
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cholinergic symptoms due to nerve agent attack: a strategy for management.
    Schecter WP
    Anesthesiol Clin North Am; 2004 Sep; 22(3):579-90, viii. PubMed ID: 15325720
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
    Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Availability, stability, and sterility of pralidoxime for mass casualty use.
    Corvino TF; Nahata MC; Angelos MG; Tschampel MM; Morosco RS; Zerkle J; Nelson RN
    Ann Emerg Med; 2006 Mar; 47(3):272-7. PubMed ID: 16492495
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of therapeutic effect of obidoxime and dosing time in the acute intoxication by chlorfenvinphos in rats.
    Raszewski G; Filip R
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):37-45. PubMed ID: 19371264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antidotes for nerve agent poisoning: should we differentiate children from adults?
    Baker MD
    Curr Opin Pediatr; 2007 Apr; 19(2):211-5. PubMed ID: 17496768
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
    Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
    Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Organophosphorus poisoning.
    Paudyal BP
    JNMA J Nepal Med Assoc; 2008; 47(172):251-8. PubMed ID: 19079407
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemical casualties. Nerve agents.
    J R Army Med Corps; 2002 Dec; 148(4):344-57. PubMed ID: 12703422
    [No Abstract]   [Full Text] [Related]  

  • 75. Antioxidant drug therapy as a neuroprotective countermeasure of nerve agent toxicity.
    Pearson-Smith JN; Patel M
    Neurobiol Dis; 2020 Jan; 133():104457. PubMed ID: 31028872
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An anesthesiological approach to nerve agent victims.
    Cosar A; Kenar L
    Mil Med; 2006 Jan; 171(1):7-11. PubMed ID: 16532866
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Accidents or terrorist attacks with chemical agents: basis for health care].
    Dueñas Laita A; Nogué Xarau S; Prados Roa F
    Med Clin (Barc); 2001 Nov; 117(14):541-54. PubMed ID: 11707222
    [No Abstract]   [Full Text] [Related]  

  • 78. Hazardous-materials antidotes.
    Vaughan WJ
    Emerg Med Serv; 2004 Apr; 33(4):71-3. PubMed ID: 15131910
    [No Abstract]   [Full Text] [Related]  

  • 79. [Overview on neurogenesis induced by organophosphate poisoning: results and perspectives].
    Lallement G
    Ann Pharm Fr; 2007 Nov; 65(6):415-21. PubMed ID: 18079674
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.